Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca ( Site 2003)

Salamanca 37007

0 studies enrolling now · 1 studies all time

What they study most

Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Studies at this site

• A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004) — Completed